Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Electrophoresis System

By Drug Discovery Trends Editor | February 18, 2008

Shimadzu’s MCE-202 MultiNA with reusable microchips automates sample processing for DNA and RNA nucleic acid, including pre-treatment, separation, detection, and data preparation, in a single device. An LED-excited fluorescence detector increases sensitivity to more than 10 times that of ethidium bromide staining, yet operating costs for this unit are comparable to or less than agarose gel electrophoresis and 25 percent less than equivalent-class microchip systems, according to the company.

The MultiNA system can register up to 120 analysis cycles, and perform efficient analysis from just one sample. By parallel processing up to four microchips, it can produce pretreatment and electrophoresis results in just 75 seconds.

The MultiNA is automatic with high-speed analysis, simple operability, high separation, and high repeatability. It uses reagent kits that correspond to separation size, automatically injecting a set quantity of reagent so it uses small amounts of important samples (as little as 2 ?L) and high-cost reagents. Simultaneous electrophoresis of an internal marker ensures analysis reliability and reproducibility.

Shimadzu’s software for the MultiNA uses size markers to automatically correct electrophoresis results for size prediction and quantitation. Users can perform either automatic or manual data analysis, and confirm completed results even as other sample analysis continues. The software includes a well status display, analysis schedule list and chip status display for current operating status.

www.ssi.shimadzu.com

See Shimaduz’s MCE-202 MultiNA at Pittcon, Booth 3755.

 


Filed Under: Genomics/Proteomics

 

Related Articles Read More >

Spatial biology: Transforming our understanding of cellular environments
DNA double helix transforming into bar graphs, blue and gold, crisp focus on each strand, scientific finance theme --ar 5:4 --personalize 3kebfev --v 6.1 Job ID: f40101e1-2e2f-4f40-8d57-2144add82b53
Biotech in 2025: Precision medicine, smarter investments, and more emphasis on RWD in clinical trials
DNA helix 3D illustration. Mutations under microscope. Decoding genome. Virtual modeling of chemical processes. Hi-tech in medicine
Genomics in 2025: How $500 whole genome sequencing could democratize genomic data
A media release and Scientific Report image of Elizabeth Kellogg. - Camera Settings: ILCE-9M2, 12mm, ISO 1000, 1/80, f/3.2, Fri, 04-19-2024 at 10:10. v.12.01.23
St. Jude pioneers gene editing and structural biology to advance pediatric research
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE